Today is Bob's 62nd birthday. In celebrating his life, I want to celebrate his lasting legacy.
On February 8th I traveled to Chapel Hill for the Fifth Annual Robert C. Millikan Cancer Epidemiology Seminar, presented by UNC Lineberger Comprehensive Cancer Center and Department of Epidemiology, Gillings School of Global Public Health. There I had the pleasure of meeting the winner of the 2018 Robert C. Millikan Cancer Epidemiology Award: Chelsea Anderson. Chelsea is a PhD candidate in Epidemiology at UNC Gillings School of Global Public Health, and a Predoctoral Fellow at Lineberger Comprehensive Cancer Center. A prolific writer, her research has been published in numerous journals, including JAMA Oncology and International Journal of Cancer.
"My research interests are focused on long-term health outcomes among cancer survivors, including second cancer events, noncancer chronic diseases, and reproductive outcomes. I am especially interested in potential late effects of cancer treatment on morbidity and mortality in long-term cancer survivors. To date, I have worked on projects focused on adolescent and young adult cancer survivors and breast cancer survivors." Chelsea Anderson
Below is a picture of Ms. Anderson with her mentor, Andrew Olshan, PhD, as she received The Robert C. Millikan Cancer Epidemiology Award. On behalf of the Millikan family, congratulations, Chelsea, and best wishes in your career!
On February 8th I traveled to Chapel Hill for the Fifth Annual Robert C. Millikan Cancer Epidemiology Seminar, presented by UNC Lineberger Comprehensive Cancer Center and Department of Epidemiology, Gillings School of Global Public Health. There I had the pleasure of meeting the winner of the 2018 Robert C. Millikan Cancer Epidemiology Award: Chelsea Anderson. Chelsea is a PhD candidate in Epidemiology at UNC Gillings School of Global Public Health, and a Predoctoral Fellow at Lineberger Comprehensive Cancer Center. A prolific writer, her research has been published in numerous journals, including JAMA Oncology and International Journal of Cancer.
"My research interests are focused on long-term health outcomes among cancer survivors, including second cancer events, noncancer chronic diseases, and reproductive outcomes. I am especially interested in potential late effects of cancer treatment on morbidity and mortality in long-term cancer survivors. To date, I have worked on projects focused on adolescent and young adult cancer survivors and breast cancer survivors." Chelsea Anderson
Below is a picture of Ms. Anderson with her mentor, Andrew Olshan, PhD, as she received The Robert C. Millikan Cancer Epidemiology Award. On behalf of the Millikan family, congratulations, Chelsea, and best wishes in your career!
This year's Seminar was given by Timothy Rebbeck, PhD, of Harvard, who was colleagues with Bob for many years. "Cancer Prevention and Early Detection in the Precision Medicine Era", was well attended by students, faculty and members of the scientific community. It gave me a chance to catch up with friends and collaborators from the "Honoring the Life and Legacy of Robert C. Millikan" events of 2015. In case you missed it, the Millikan Symphony CD was released in 2017! I was also pleased to learn that one of Bob's former students, Melissa Troester, PhD, is now a full Professor at Gillings, and the new PI of the Carolina Breast Cancer Study (CBCS), a landmark study Bob directed for 16 years. Below is a picture of Dr. Rebbeck presenting the Fifth Annual Robert C. Millikan Cancer Epidemiology Seminar.
Happy Birthday, my dear brother. Your legacy continues.